TEVA 7032 (Mycophenolic Acid Delayed-Release 360 mg)
Pill with imprint TEVA 7032 is Orange, Capsule-shape and has been identified as Mycophenolic Acid Delayed-Release 360 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Mycophenolic acid is used in the treatment of rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7032
Mycophenolic Acid Delayed-Release
- Imprint
- TEVA 7032
- Strength
- 360 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7032 (Discontinued)
More about mycophenolic acid
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: selective immunosuppressants
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.